Bladder Wall Thickness for Treatment Response in Children With Lower Urinary Tract Dysfunction or Enuresis

June 16, 2026 updated by: Furkan Adem Canbaz, Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Predictive Value of Bladder Wall Thickness for Treatment Response in Children With Lower Urinary Tract Dysfunction or Enuresis

This study aims to evaluate the association between bladder wall thicknes and treatment response in children presenting with enuresis or lower urinary tract dysfunction.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Detailed Description

A total of approximately 120 patients who had bladder wall measurements before treatment will be evaluated retrospectively. Treatment success rates among these patients will be evaluated. Patients will be divided into mainly two groups according to the diagnosis.

Study Type

Observational

Enrollment (Estimated)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Sancaktepe
      • Istanbul, Sancaktepe, Turkey (Türkiye), 34000
        • Sancaktepe Ilhan Varank Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients admitted to the Pediatric Urology Clinic of Sancaktepe Şehit Prof. Dr. İlhan Varank Training and Research Hospital for enuresis or lower urinary tract disorders and underwent evaluation for bladder wall thickness using ultrasonography.

Description

Inclusion Criteria:

  • Diagnosed with lower urinary tract disorder or enuresis
  • Undergoing transabdominal ultrasonographic measurement of bladder wall thickness
  • Patients between 5-17 years old

Exclusion Criteria:

  • Patients with neurogenic voiding dysfunction
  • Lack of data

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Enuresis
Patients with a diagnosis of enuresis who had bladder wall measurements before treatment
Diagnostic test: Bladder Wall Thickness Measurement by Ultrasonography
Transabdominal ultrasonographic measurement of bladder wall thickness was performed in children with enuresis and lower urinary tract symptoms to evaluate its diagnostic value and predictive value for treatment response.
Lower urinary tract disorder
Patients with a diagnosis of lower urinary tract disorder who had bladder wall measurements before treatment
Diagnostic test: Bladder Wall Thickness Measurement by Ultrasonography
Transabdominal ultrasonographic measurement of bladder wall thickness was performed in children with enuresis and lower urinary tract symptoms to evaluate its diagnostic value and predictive value for treatment response.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Bladder Wall Thickness Measured by Ultrasonography in Children With Lower Urinary Tract Symptoms and Enuresis
Time Frame: Baseline
Bladder wall thickness measured by transabdominal ultrasonography and compared between children with lower urinary tract symptoms and those with enuresis.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2024

Primary Completion (Estimated)

August 1, 2026

Study Completion (Estimated)

August 1, 2026

Study Registration Dates

First Submitted

June 16, 2026

First Submitted That Met QC Criteria

June 16, 2026

First Posted (Actual)

June 18, 2026

Study Record Updates

Last Update Posted (Actual)

June 18, 2026

Last Update Submitted That Met QC Criteria

June 16, 2026

Last Verified

June 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Bladder wall thickness

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

I have no idea about it.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Urinary Tract Disorder

Clinical Trials on Bladder Wall Thickness Measurement by Ultrasonography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ethiopia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe